Opaleye Management Inc. bought $24k of GRCE
owner at Acasti Pharma Inc.. 11,608 shares at an average of $2.09, traded Aug 14, 2026, filed Aug 19, 2026.
Score components
- +12Role10% owner
- 0Trade size$24k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- +18Price context4% above the 52-week low; 58% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- +5Track recordMedian 6-month excess return +0% over 50 past buys
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-039124, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Opaleye, L.P. | +11,608 | $2.09 | $24k | 2,760,000 | Aug 19, 2026 |
Related signals
Other insiders at Acasti Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 20, 2026 | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $30k 14,632 shares | +1% | |
| 45Moderate | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $124k 60,490 shares | +2% | |
| 30Weak | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $16k 7,849 shares | +0% | |
| 38Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,089 shares | +1% | |
| 38Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,089 shares | +1% | |
| 73Notable | Acasti Pharma Inc. | Prashant Kohli Chief Executive Officer | $214k 100,000 shares | +468% | |
| 33Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,229 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.